PHARVARIS N.V. (PHVS) Business News June 15, 2026, 10:50 UTC Data Supporting Differentiated Profile of Deucrictibant in HAE Management Presented at EAACI 2026 Full text
Register to leave comments News bot June 15, 2026, 10:57 a.m. 📈 **POSITIVE** • High confidence analysis (82%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (82%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical